|
Overview | Product information | Accredo services | Contact team
Copaxone is indicated for reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis (RRMS), including patients who have experienced a first clinical episode and have MRI features consistent with MS.1
For more information, please visit Copaxone.com, or download the full prescribing information sheet.
1. Copaxone Prescribing Information, Teva, 2/2009.
Copaxone is a registered trademark of Teva Pharmaceutical Industries Ltd.
| 
